• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮症倾向2型糖尿病的管理

Management of ketosis-prone type 2 diabetes mellitus.

作者信息

Smolenski Stefan, George Nancy M

机构信息

Wayne State University College of Nursing, Detroit, Michigan.

出版信息

J Am Assoc Nurse Pract. 2019 Jul;31(7):430-436. doi: 10.1097/JXX.0000000000000183.

DOI:10.1097/JXX.0000000000000183
PMID:30829978
Abstract

Diabetic ketoacidosis (DKA) has largely been considered unique to type 1 diabetes because of the absolute lack of insulin production secondary to beta-cell dysfunction. However, a relatively new diabetes subtype known as ketosis-prone type 2 diabetes mellitus (DM) may also elicit diabetic ketoacidosis. Ketosis-prone type 2 DM shares a similar pathophysiology as type 2 DM, but presents initially with signs and symptoms consistent with type 1 DM. Patients with ketosis-prone type 2 DM often present with elevated glucose levels of 500-700 mg/dl, elevated ketone levels, and elevations in hemoglobin A1C. Unlike DKA seen in type 1 DM, they do not exhibit autoantibodies to beta cells. The similarity with type 1 DM exists in their impaired insulin secretion, which, when combined with extreme insulin resistance, will lead to ketoacidosis. Despite the initial clinical presentation that resembles type 1 DM, patients may not require lifelong insulin and achieve appropriate glycemic control with oral agents. Nurse practitioners must recognize the clinical picture of ketosis-prone type 2 DM and use a multifaceted approach, encouraging dietary changes, increased physical activity, and medication adherence to build the self-management skills of the patient and ultimately decrease the long-term disease burden.

摘要

由于β细胞功能障碍导致绝对缺乏胰岛素分泌,糖尿病酮症酸中毒(DKA)在很大程度上被认为是1型糖尿病所特有的。然而,一种相对较新的糖尿病亚型,即易发生酮症的2型糖尿病(DM),也可能引发糖尿病酮症酸中毒。易发生酮症的2型糖尿病与2型糖尿病具有相似的病理生理学,但最初表现出与1型糖尿病一致的体征和症状。易发生酮症的2型糖尿病患者通常血糖水平升高至500 - 700mg/dl,酮体水平升高,糖化血红蛋白(A1C)也升高。与1型糖尿病中所见的糖尿病酮症酸中毒不同,他们不会表现出针对β细胞的自身抗体。其与1型糖尿病的相似之处在于胰岛素分泌受损,当与极端胰岛素抵抗相结合时,会导致酮症酸中毒。尽管最初的临床表现类似于1型糖尿病,但患者可能不需要终身使用胰岛素,通过口服药物即可实现适当的血糖控制。执业护士必须认识到易发生酮症的2型糖尿病的临床表现,并采用多方面的方法,鼓励饮食改变、增加体育活动以及坚持用药,以培养患者的自我管理技能,最终减轻长期疾病负担。

相似文献

1
Management of ketosis-prone type 2 diabetes mellitus.酮症倾向2型糖尿病的管理
J Am Assoc Nurse Pract. 2019 Jul;31(7):430-436. doi: 10.1097/JXX.0000000000000183.
2
Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes.酮症倾向 2 型糖尿病中β细胞功能障碍无脂毒性作用。
Diabetes Care. 2010 Mar;33(3):626-31. doi: 10.2337/dc09-1369. Epub 2009 Dec 22.
3
A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.一例特发性1型糖尿病患者,尽管最初诊断为暴发性1型糖尿病,但随后内源性胰岛素分泌恢复。
Endocr J. 2017 Mar 31;64(3):369-374. doi: 10.1507/endocrj.EJ16-0245. Epub 2017 Jan 6.
4
Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes.喀麦隆高血糖危象患者中易发生酮症的非典型糖尿病:发病率、临床和代谢表型
Diabet Med. 2017 Mar;34(3):426-431. doi: 10.1111/dme.13264. Epub 2016 Oct 15.
5
Ketosis prone diabetes presenting as fulminant type 1 diabetes.以暴发性1型糖尿病形式出现的酮症倾向糖尿病。
Pan Afr Med J. 2018 Sep 20;31:38. doi: 10.11604/pamj.2018.31.38.16162. eCollection 2018.
6
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.糖尿病酮症酸中毒:2型糖尿病非裔美国人中糖尿病常见的首发症状
Endocr Pract. 2017 Aug;23(8):971-978. doi: 10.4158/EP161679.RA. Epub 2017 May 23.
7
Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans.撒哈拉以南非洲人中的酮症倾向2型糖尿病与人类疱疹病毒8感染
JAMA. 2008 Jun 18;299(23):2770-6. doi: 10.1001/jama.299.23.2770.
8
Bodyweight threshold for sudden onset of ketosis might exist in ketosis-prone type 2 diabetes patients.体重阈值可能存在于易发生酮症的 2 型糖尿病患者的酮症发作中。
J Diabetes Investig. 2020 Mar;11(2):499-501. doi: 10.1111/jdi.13120. Epub 2019 Aug 14.
9
Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes.胰岛素肽特异性γ干扰素相关免疫反应在酮症倾向2型糖尿病中的临床意义
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2124-e2132. doi: 10.1210/clinem/dgab912.
10
Heterogeneous clinical features of ketosis-prone type 2 diabetes mellitus patients: gender, age, loss of weight and HbA1c.酮症倾向2型糖尿病患者的异质性临床特征:性别、年龄、体重减轻及糖化血红蛋白
Minerva Endocrinol. 2019 Dec;44(4):351-356. doi: 10.23736/S0391-1977.18.02925-5. Epub 2018 Nov 26.

引用本文的文献

1
New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib.在接受伊马替尼治疗的慢性粒细胞白血病患者中出现以糖尿病酮症酸中毒为表现的新发糖尿病。
Arch Endocrinol Metab. 2025 Apr 8;69(2):e240432. doi: 10.20945/2359-4292-2024-0432.
2
Olanzapine-Induced Diabetic Ketoacidosis: A Reversible Etiology Overlooked in Psychiatric Patients.奥氮平诱发的糖尿病酮症酸中毒:一种在精神科患者中被忽视的可逆病因。
AACE Clin Case Rep. 2023 Oct 19;10(1):14-16. doi: 10.1016/j.aace.2023.10.006. eCollection 2024 Jan-Feb.
3
Partial Remission of Diabetes in a Young Adult While Testing Positive for Several Islet Cell Autoantibodies: A Case Report, Literature Review, and Patient Perspective.
一名年轻成人糖尿病部分缓解且多种胰岛细胞自身抗体检测呈阳性:病例报告、文献综述及患者视角
Cureus. 2022 Jun 8;14(6):e25746. doi: 10.7759/cureus.25746. eCollection 2022 Jun.
4
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I.用于2型糖尿病和代谢综合征的降糖药物——经典与新型化合物综述:第一部分
Pharmaceuticals (Basel). 2019 Oct 10;12(4):152. doi: 10.3390/ph12040152.